Table 3.
Clinical outcomes.
| COVID-19 suspected (n = 48) | COVID-19 less likely (n = 59) | |||
| Final diagnosis | ||||
| COVID-19 | 9 | 18.8% | 0 | 0.0% |
| Not COVID-19 | 39 | 81.2% | 59 | 100% |
| Respiratory infection | 23 | 47.9% | 28 | 47.5% |
| Other focal infection (meningitis) | 7 (2) | 14.6% (4.2%) | 15 (2) | 25.4% (3.4%) |
| Interstitial pneumoniae | 4 | 8.3% | 0 | 0.0% |
| Tumor-related fever | 2 | 4.2% | 3 | 5.1% |
| Collagen disease | 0 | 0.0% | 2 | 3.4% |
| Acute myocardial infarction | 0 | 0.0% | 1 | 1.7% |
| Others | 3 | 6.3% | 10 | 16.9% |
| Clinical outcome | ||||
| Death | 1 | 2.1% | 1 | 1.7% |
| Hospitalization | 31 | 64.6% | 20 | 33.9% |
| Not hospitalized | 17 | 35.4% | 39 | 66.1% |